PCM
LYRA

Pentwater Capital Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Pentwater Capital Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,200
Closed -$241K – 202
2022
Q1 		$241K Sell
1,200
-226
-16% -$49.6K ﹤0.01% 159
2021
Q4 		$311K Buy
1,426
+786
+123% +$253K ﹤0.01% 194
2021
Q3 		$292K Buy
640
+164
+34% +$62K ﹤0.01% 223
2021
Q2 		$191K Hold
476
– – ﹤0.01% 285
2021
Q1 		$276K Hold
476
– – ﹤0.01% 315
2020
Q4 		$271K Hold
476
– – ﹤0.01% 218
2020
Q3 		$266K Hold
476
– – ﹤0.01% 207
2020
Q2 		$270K Buy
+476
New +$348K ﹤0.01% 142

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Pentwater Capital Management's LYRA Position: Q2 2022 in Review

Pentwater Capital Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2022, closing a stake of 1,200 shares — an estimated $241K sold.

Pentwater Capital Management first reported a position in LYRA in Q2 2020 and held it in 8 quarters. The position peaked at $311K in Q4 2021. 36 funds tracked by Wall St. Rank hold LYRA as of Q2 2022.

  • Pentwater Capital Management reported no remaining LYRA THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Pentwater Capital Management sold 1,200 LYRA THERAPEUTICS INC shares in Q2 2022, an estimated $241K.
  • Pentwater Capital Management first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 8 quarters.
  • Pentwater Capital Management's LYRA THERAPEUTICS INC position peaked at $311K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2022.

Based on Pentwater Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.